Abstract: A system for interfacing with an operator's body for distributing forces to the operator's body received by the system from a function unit. The system includes a frame and a plurality of contact units connected to the frame which are positioned and communicate with the operator's torso to distribute the received forces. The plurality of contact units each include a first and second support having an elastic body positioned therebetween which allows relative movement between the first and second supports.

Abstract: A system for interfacing with an operator's body for distributing forces to the operator's body received by the system from a function unit. The system includes a frame and a plurality of contact units connected to the frame which are positioned and communicate with the operator's torso to distribute the received forces. The plurality of contact units each include a first and second support having an elastic body positioned therebetween which allows relative movement between the first and second supports.

Abstract: A pharmaceutical composition for use in antineoplastic therapy in mammals, including humans, comprising a biologically active ureido compound of formula (I) wherein each of m and n, being the same, is an integer of 1 to 3; and each of the R groups, which are the same, is a naphthyl group substituted by 1 to 3 sulfonic groups, or a pharmaceutically acceptable salt thereof, and an antineoplastic agent selected from the group consisting of an antineoplastic vinca alkaloid, an antineoplastic antibiotic, an antineoplastic antimetabolite, an antineoplastic platinum coordination complex, an antineoplastic taxane compound, an antineoplastic ceramide compound, an antineoplastic distamycin compound, an antineoplastic epidophyllotoxin compound and an antineoplastic topoisomerase I inhibitor, and a pharmaceutically acceptable carrier or excipient, in amounts effective to produce a synergistic antineoplastic effect, is provided herein.

Abstract: The invention relates to the use of compounds of formula (I) ##STR1## wherein each of m and n, being the same, is an integer of 1 to 3; and each of the R groups, which are the same, is a naphthyl group substituted by 1 to 3 sulfonic groups,or pharmaceutically acceptable salts thereof, in the preparation of a medicament for use in preventing and/or treating the metastatic spread of tumors.